TY - JOUR T1 - British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic JF - Gut JO - Gut SP - 984 LP - 990 DO - 10.1136/gutjnl-2020-321244 VL - 69 IS - 6 AU - Nicholas A Kennedy AU - Gareth-Rhys Jones AU - Christopher A Lamb AU - Richard Appleby AU - Ian Arnott AU - R Mark Beattie AU - Stuart Bloom AU - Alenka J Brooks AU - Rachel Cooney AU - Robin J Dart AU - Cathryn Edwards AU - Aileen Fraser AU - Daniel R Gaya AU - Subrata Ghosh AU - Kay Greveson AU - Richard Hansen AU - Ailsa Hart AU - A Barney Hawthorne AU - Bu'Hussain Hayee AU - Jimmy K Limdi AU - Charles D Murray AU - Gareth C Parkes AU - Miles Parkes AU - Kamal Patel AU - Richard C Pollok AU - Nick Powell AU - Chris S Probert AU - Tim Raine AU - Shaji Sebastian AU - Christian Selinger AU - Philip J Smith AU - Catherine Stansfield AU - Lisa Younge AU - James O Lindsay AU - Peter M Irving AU - Charlie W Lees Y1 - 2020/06/01 UR - http://gut.bmj.com/content/69/6/984.abstract N2 - The COVID-19 pandemic is putting unprecedented pressures on healthcare systems globally. Early insights have been made possible by rapid sharing of data from China and Italy. In the UK, we have rapidly mobilised inflammatory bowel disease (IBD) centres in order that preparations can be made to protect our patients and the clinical services they rely on. This is a novel coronavirus; much is unknown as to how it will affect people with IBD. We also lack information about the impact of different immunosuppressive medications. To address this uncertainty, the British Society of Gastroenterology (BSG) COVID-19 IBD Working Group has used the best available data and expert opinion to generate a risk grid that groups patients into highest, moderate and lowest risk categories. This grid allows patients to be instructed to follow the UK government’s advice for shielding, stringent and standard advice regarding social distancing, respectively. Further considerations are given to service provision, medical and surgical therapy, endoscopy, imaging and clinical trials. ER -